bioRxiv · 10.1101/2023.07.24.550346
Discovering genetic biomarkers for targeted cancer therapeutics with eXplainable AI
Abstract
Explainable Artificial Intelligence (XAI) enables a holistic understanding of the complex and nonlinear relationships between genes and prognostic outcomes of cancer patients. In this study, we focus on a distinct aspect of XAI - to generate accurate and biologically relevant hypotheses and provide a shorter and more creative path to advance medical research. We present an XAI-driven approach to discover otherwise unknown genetic biomarkers as potential therapeutic targets in high-grade serous ovarian cancer, evidenced by the discovery of IL27RA, which leads to reduced peritoneal metastases when knocked down in tumor-carrying mice given IL27-siRNA-DOPC nanoparticles. SummaryExplainable Artificial Intelligence is amenable to generating biologically relevant testable hypotheses despite their limitations due to explanations originating from post hoc realizations.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Chakraborty, D., Gutierrez-Chakraborty, E. P., Rodriguez-Aguayo, C., Basagaoglu, H., Lopez-Berestein, G., Amero, P.. 2023-07-26. Discovering genetic biomarkers for targeted cancer therapeutics with eXplainable AI. https://doi.org/10.1101/2023.07.24.550346
Cite the original work for its findings. Save a collection to share your selection of sources.